4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001628280-22-026822
Options or other derivatives
- Director acquired 9,006 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelly Michael Aaron Director | 2022-10-19 | Grant or award · Stock Option (right to buy) | +9,006 | 9,006 | D | ||
Loading xslF345X03/wf-form4_166638421646853.xml…